ALL THE NEWS
Tap Oil picks up two offshore blocks in 2014 acreage raffle
/in Uncategorized /by Wally GrahamTHE ROADHOUSE BOWSER: Tap Oil (ASX: TAP) has been awarded 100 per cent interest of Blocks W14-7 and W14-16 in the Barrow and Dampier sub-basins on the North West Shelf. The two blocks were offered under the 2014 Offshore Petroleum Exploration Acreage Release. W14-07, now Petroleum Exploration Permit WA-515-P, is located on the Rankin Platform […]
Capital Mining stakes claim in Canadian medical cannabis market
/in Uncategorized /by Wally GrahamTHE ROADHOUSE PHARMACY: Capital Mining (ASX: CMY) has signed a binding Heads of Agreement, under which the company claims it will become the first ASX-listed company to hold a direct stake in a licensed grower, manufacturer and distributor of medical cannabis products under Canada’s Marijuana for Medical Purposes Regulations (MMPR). The stake is to come […]
Hi Ho, Hi Ho, it’s off to work we go
/in The Drill Sergeant /by Wally GrahamTHE DRILL SERGEANT: Each week any number of junior exploration plays set out to drill their ground. Here’s a small selection of what’s been happening this week. Resource Development Drilling Ausgold (ASX: AUC) has drilling scheduled to commence at the company’s Katanning gold project, on the Dingo and Jinkas projects during late March. Ausgold proposes […]
What the Analysts Say
/in Uncategorized /by Wally GrahamWHAT THE ANALYSTS SAY: Interesting news and views from across the Resource Analyst universe. Website: www.breakawayresearch.com Company: Metallica Minerals Limited (ASX: MLM) Metallica Minerals has a diverse portfolio of projects in Queensland. The company is concentrating on its 66.66 per cent (reducing to 50 per cent) held Cape York heavy mineral sands (HMS) and bauxite […]
PDAC showcases potential of Australian sector
/in Uncategorized /by Wally GrahamCONFERENCE CORRESPONDENT: It may have been minus 10 degrees in Toronto but the cold weather didn’t stop over 20000 mining types assembling at this year’s Prospectors & Developers Association of Canada (PDAC) Conference in Toronto. The mood of the conference was as cautious and circumspect as anywhere else at the moment with plenty of small […]
David Busch – Argent Minerals
/in Uncategorized /by Wally GrahamONE OFF THE WOOD: Argent Minerals managing director David Busch dropped by The Roadhouse this week to give us an update on the latest drilling campaign currently underway at the company’s Kempfield polymetallic project. Argent Minerals’ (ASX: ARD) Kempfield polymetallic project has a JORC Code (2012)-compliant Mineral Resource of 21.8 million tonnes for 52 million […]
Sedgman awarded $18.5M Mineral Sands Plant contract
/in The Bourse Whisperer /by Wally GrahamTHE BOURSE WHISPERER: Resources sector services company Sedgman (ASX: SDM) has been awarded an $18.5 million contract as Principal Contractor for a Relocatable Modular Mineral Sands Wet Concentrator Plant to be constructed at Twin Pines Minerals’ (TPM) New Jersey facility in the United States of America. Sedgman said the facility will eventually process 232 tonnes […]
Talga Resources to build German graphite plant
/in The Bourse Whisperer /by Wally GrahamTHE BOURSE WHISPERER: Talga Resources (ASX: TLG) has announced it will build and commission a demonstration-scale graphene production plant in central Germany. At this stage all costings and engineering are subject to final design work, however the company said it anticipates the plant will cost less than $1 million and, once commissioned, should scale-up to […]
Eneabba Gas to expand Perth Basin portfolio
/in Uncategorized /by Wally GrahamTHE ROADHOUSE BOWSER: Eneabba Gas (ASX: ENB) has entered into a binding Heads of Agreement with Greenpower Energy (ASX: GPP) for an option to acquire 100 per cent of the issued capital of the latter’s wholly-owned subsidiary, GCC Methane. GCC owns a 50 per cent interest in Exploration Permit 447 (EP447), located in the Perth […]
Novogen US studies confirm drug’s cancer-kill capability
/in Uncategorized /by Wally GrahamTHE ROADHOUSE PHARMACY: Novogen Limited (ASX: NRT) has claimed to have confirmed one of its lead candidate products, TRXE-009, is showing potential to become a new therapy in the fight against adult and pediatric brain cancer. The company said its latest study looked at the ability of TRXE-009 to kill a library of patient-derived cell […]